These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 16949464

  • 1. Dialysis adequacy and response to erythropoiesis-stimulating agents: what is the evidence base?
    Locatelli F, Del Vecchio L, Pozzoni P, Andrulli S.
    Semin Nephrol; 2006 Jul; 26(4):269-74. PubMed ID: 16949464
    [Abstract] [Full Text] [Related]

  • 2. Dialysis adequacy and response to erythropoietic agents: what is the evidence base?
    Locatelli F, Del Vecchio L.
    Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii29-35. PubMed ID: 14607998
    [Abstract] [Full Text] [Related]

  • 3. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients.
    Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K.
    J Am Soc Nephrol; 2006 Apr; 17(4):1181-91. PubMed ID: 16565261
    [Abstract] [Full Text] [Related]

  • 4. Management of anemia by convective treatments.
    Locatelli F, Manzoni C, Del Vecchio L, Di Filippo S, Pontoriero G, Cavalli A.
    Contrib Nephrol; 2011 Apr; 168():162-172. PubMed ID: 20938137
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
    Qureshi IZ, Abid K, Ambreen F, Qureshi AL.
    Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
    [Abstract] [Full Text] [Related]

  • 6. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R, Besarab A, Macdougall IC, Ellison DH, Maxwell AP, Sulowicz W, Klinger M, Rutkowski B, Correa-Rotter R, Dougherty FC, BA 16528 Study Investigators.
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [Abstract] [Full Text] [Related]

  • 7. It's time to compare anemia management strategies in hemodialysis.
    Coyne DW.
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):740-2. PubMed ID: 20299363
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correcting iron-restricted erythropoiesis and improving anemia in patients on hemodialysis: practical tips that can make a difference.
    Easom A.
    Nephrol Nurs J; 2009 Apr; 36(5):529-37, 553. PubMed ID: 19856814
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease.
    Fishbane S.
    Blood Purif; 2007 Apr; 25(1):53-7. PubMed ID: 17170538
    [Abstract] [Full Text] [Related]

  • 14. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW, Shetty S, del Aguila MA, Nelson MA, Murray BM.
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [Abstract] [Full Text] [Related]

  • 15. [Comorbidity, anemia and response to erythropoiesis stimulating agents in chronic hemodialysis].
    Anaya S, Rivera F, Sánchez de la Nieta MD, Carreño A, Vozmediano C, Alcaide MP, Arambarri M, Nieto J, Caparrós G, Ferreras I.
    Nefrologia; 2008 Nov; 28(2):186-92. PubMed ID: 18454709
    [Abstract] [Full Text] [Related]

  • 16. Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis play a role?
    Dahl NV, Henry DH, Coyne DW.
    Semin Dial; 2008 Nov; 21(3):210-1. PubMed ID: 18397204
    [Abstract] [Full Text] [Related]

  • 17. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Nov; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.